
Sacubitril 24 mg/Valsartan 26 mg Tablets, 60 Tablets/Bottle
- UPC
- 00372205280601
- Manufacturer:
- NOVADOZ PHARM
- Form
- TABLET
- Unit size
- 60
- Strength
- 24-26MG
Details
Details
Sacubitril and Valsartan — 24-26MG, Film-coated tablet, bottle of 60 tablets
Sacubitril and Valsartan is a film-coated tablet for oral use. Sacubitril and valsartan tablets are a combination of sacubitril, a neprilisin inhibitor, and valsartan, an angiotensin II receptor blocker, and is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure and reduced ejection fraction. ( 1.1 ) for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. Sacubitril and valsartan tablets reduces NT-proBNP and is expected to improve cardiovascular outcomes. ( 1.2 ) 1.1 Adult Heart Failure Sacubitril and valsartan tablets are indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure and reduced ejection fraction.
- Active ingredient or product type: SACUBITRIL; VALSARTAN
- Strength/concentration: 24-26MG
- Dosage form and route: Film-coated tablet, Oral
- Exact package presentation: bottle of 60 tablets
- NDC/item number: 72205-280-60
- Manufacturer: NOVADOZ PHARM
- Storage/handling: Store at 25°C (77°F), excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from moisture.
- Status: Rx only
Important safety information: • Observe for signs and symptoms of angioedema and hypotension. ( 5.2 , 5.3 ) • Monitor renal function and potassium in susceptible patients. ( 5.4 , 5.5 ) 5.1 Fetal Toxicity Sacubitril and valsartan can cause fetal harm when administered to a pregnant woman.
Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.